Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Another 20 concessionary prices announced for October

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 20 items for October 2018 prescriptions.

An initial nine concessionary prices for October were announced last week, with a further 15 agreed on Monday.

 
Drug
Strength
Form
Price
Allopurinol
100mg
tablets (28)
£2.54
Allopurinol
300mg
tablets (28)
£5.83
Furosemide
40mg
tablets (28)
£2.49
Lamotrigine
50mg
tablets (56)
£8.95
Lamotrigine
100mg
tablets (56)
£20.76
Lamotrigine
200mg
tablets (56)
£24.17
Lercanidipine
10mg
tablets (28)
£4.02
Lercanidipine
20mg
tablets (28)
£7.87
Losartan
50mg
tablets (28)
£1.40
Naproxen
250mg
tablets (28)
£2.30
Nebivolol
5mg
tablets (28)
£6.54
Ondansetron
4mg
tablets (10)
£16.59
Ramipril
2.5mg
tablets (28)
£3.93
Risperidone
1mg
tablets (20)
£4.80
Risperidone
2mg
tablets (60)
£1.80
Risperidone
3mg
tablets (60)
£37.02
Risperidone
4mg
tablets (60)
£25.70
Risperidone
500mcg
tablets (20)
£3.03
Sevelamer
800mg
tablets (180)
£60.02
Telmisartan
40mg
tablets (28)
£9.31

Do these prices reflect the ones you paid in October?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel